Literature DB >> 32255383

Biological treatment use amid the COVID-19 era, a close look at the unresolved perplexity.

Mohammed Shanshal1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 32255383     DOI： 10.1080/09546634.2020.1752886

Source DB:  PubMed          Journal:  J Dermatolog Treat        ISSN： 0954-6634            Impact factor:   3.359


× No keyword cloud information.
  3 in total

1.  Efficacy and safety of current therapeutic options for COVID-19 - lessons to be learnt from SARS and MERS epidemic: A systematic review and meta-analysis.

Authors:  Han Zhong; Yan Wang; Zai-Li Zhang; Yang-Xi Liu; Ke-Jia Le; Min Cui; Yue-Tian Yu; Zhi-Chun Gu; Yuan Gao; Hou-Wen Lin
Journal:  Pharmacol Res       Date:  2020-04-30       Impact factor: 7.658

2.  Cutaneous manifestations and considerations in COVID-19 pandemic: A systematic review.

Authors:  Farnoosh Seirafianpour; Sogand Sodagar; Arash Pour Mohammad; Parsa Panahi; Samaneh Mozafarpoor; Simin Almasi; Azadeh Goodarzi
Journal:  Dermatol Ther       Date:  2020-08-06       Impact factor: 3.858

3.  No evidence of increased risk for Coronavirus Disease 2019 (COVID-19) in patients treated with Dupilumab for atopic dermatitis in a high-epidemic area - Bergamo, Lombardy, Italy.

Authors:  A Carugno; F Raponi; A G Locatelli; P Vezzoli; D M Gambini; M Di Mercurio; E Robustelli Test; P Sena
Journal:  J Eur Acad Dermatol Venereol       Date:  2020-06-15       Impact factor: 9.228
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.